Global Keloid Treatment Market Size By Type (Occlusive Dressing, Compression Therapy), By Application (Hospitals, Dermatology Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Keloid Treatment Market was valued at USD 4.1 billion in 2023 and is projected to reach USD 7.9 billion by 2031, growing at a CAGR of 8.3% during the forecast period from 2023 to 2031. The rising prevalence of skin disorders, advancements in dermatological therapies, and increasing demand for aesthetic and minimally invasive treatments are the major factors driving market growth. Keloids, which are overgrowths of scar tissue at the site of a healed skin injury, present both cosmetic and physical discomfort. As awareness increases about treatment options, the global keloid treatment market continues to expand steadily.

Drivers:

1. Increasing Incidence of Skin Injuries and Surgical Scars

Keloids often form after surgeries, burns, acne, or piercings. With the global rise in aesthetic procedures and surgeries, cases of keloid formation have also grown, leading to a higher demand for treatment solutions.

2. Technological Advancements in Dermatology

Innovations such as laser therapy, cryotherapy, and intralesional corticosteroid injections have significantly improved keloid treatment efficacy and patient outcomes. These advancements are attracting a wider demographic toward treatment.

3. Rising Demand for Aesthetic Appearance

The growing emphasis on personal aesthetics, especially among younger populations and in urban regions, is propelling demand for treatments that effectively minimize visible scars and keloids.

Restraints:

1. High Cost of Advanced Therapies

Some treatment modalities, particularly laser therapies and surgical removal followed by radiation, can be expensive and not universally covered by insurance, especially in emerging economies.

2. Risk of Recurrence

Despite advancements, keloids are known for their high recurrence rates, particularly if not treated properly. This factor can deter patients and complicate treatment planning for dermatologists.

Opportunity:

1. Increasing Penetration in Emerging Markets

Developing countries in Asia-Pacific and Latin America are witnessing growth in medical infrastructure and rising disposable incomes. This opens doors for broader adoption of keloid treatments, especially minimally invasive and outpatient procedures.

2. Product Innovation and Combination Therapies

The development of combination therapies—using corticosteroids, silicone sheets, and laser therapy together—is showing improved efficacy in managing keloids. This trend presents an opportunity for companies to create more tailored treatment solutions.

Market by System Type Insights:

The market can be categorized into corticosteroid injections, laser therapy, cryotherapy, surgical excision, silicone gel/sheets, and radiation therapy. In 2023, corticosteroid injections accounted for the largest market share due to their widespread use, cost-effectiveness, and established clinical efficacy. However, the laser therapy segment is expected to witness the fastest growth owing to its non-invasive nature, minimal downtime, and increasing patient preference.

Market by End-use Insights:

By end-use, the market is segmented into hospitals, dermatology clinics, and aesthetic centers. Dermatology clinics dominated the market in 2023, supported by their specialized capabilities in handling scar treatments and access to innovative technologies. However, aesthetic centers are anticipated to show strong growth, as consumers increasingly opt for cosmetic procedures in non-hospital settings.

Market by Regional Insights:

North America led the global keloid treatment market in 2023 due to the presence of advanced healthcare infrastructure, a high number of dermatology clinics, and greater awareness about treatment options. Asia-Pacific, on the other hand, is expected to witness the fastest growth during the forecast period, fueled by the growing medical tourism industry, rising disposable incomes, and increasing focus on cosmetic healthcare.

Competitive Scenario:

Key players in the global keloid treatment market include Smith & Nephew, Merz Pharmaceuticals, Sonoma Pharmaceuticals, Lumenis, Perrigo Company plc, Revitol, RXi Pharmaceuticals, and ScarAway. These companies are investing in R&D, launching new therapeutic options, and expanding their presence in high-growth regions. For instance:

In 2023, Lumenis introduced a new generation of aesthetic lasers designed specifically for scar and keloid treatment.

Merz Pharmaceuticals expanded its portfolio of dermal therapeutics through acquisitions aimed at improving scar and wound healing products.

In 2024, RXi Pharmaceuticals received FDA clearance for a siRNA-based therapy targeting abnormal scar formation, including keloids.

Scope of Work – Global Keloid Treatment Market

Report Metric Details

Market Size (2023) USD 4.1 Billion

Projected Market Size (2031) USD 7.9 Billion

CAGR (2023-2031) 8.3%

Market Segments By Treatment Type (Corticosteroids, Laser, Cryotherapy, Surgery), End-use

Growth Drivers Rise in aesthetic awareness, increased incidence of keloids, technology

Opportunities Emerging markets, combination therapies, product innovation

Key Market Developments:

2023: Smith & Nephew launched a next-gen silicone gel sheet designed for both prevention and treatment of keloids.

2024: RXi Pharmaceuticals advanced its RNAi-based therapeutic pipeline, targeting hypertrophic and keloid scars.

2025: Merz Pharma entered a partnership with a leading cosmetic chain in Asia to expand access to laser-based keloid treatments.

FAQs:

1. What is the current market size of the Global Keloid Treatment Market?

The market size was valued at USD 4.1 billion in 2023.

2. What is the major growth driver of the Global Keloid Treatment Market?

Increasing demand for aesthetic procedures and technological advancements in dermatology are key drivers.

3. Which is the largest region during the forecast period in the Global Keloid Treatment Market?

North America accounted for the largest market share in 2023.

4. Which segment accounted for the largest market share in the Global Keloid Treatment Market?

Corticosteroid injections led the market by treatment type in 2023.

5. Who are the key market players in the Global Keloid Treatment Market?

Key players include Smith & Nephew, Merz Pharmaceuticals, Sonoma Pharmaceuticals, Lumenis, RXi Pharmaceuticals, and ScarAway.